Radical transurethral resection in the management of muscle-invasive bladder cancer

Journal of Endourology

Volumn 15, Issue 4, 2001, Pages 419-423

  Grob, B Mayer ^a   Macchia, Richard J ^a  

^a SUNY Downstate Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; EPIRUBICIN; METHOTREXATE; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CYSTECTOMY; HUMAN; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRANSURETHRAL RESECTION; TREATMENT INDICATION;

EID: 0034999296     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/089277901300189475     Document Type: Article

References (21)

1. Jacobsen F, Lundbeck F, Vaeth M, Kjaer TB. Transurethral treatment of invasive tumors of the urinary bladder (T1, T2): Recurrence and prognosis. Scand J Urol Nephrol 1987;104:123.
2. Flocks RH. Treatment of patients with carcinoma of the bladder. JAMA 1951;145:295.
3. Pagano F, Bassi P, Galetti TP, Meneghini A, Milani C, Artibani W, Garbeglio A. Results of contemporary radical cystectomy for invasive bladder cancer: A clinicopathological study with an emphasis on the inadequacy of The Tumor, Nodes, and Metastases classification. J Urol 1991;145:45.
4. Stroumbakis N, Herr HW, Cookson MS, Fair WR. Radical cystectomy in the octogenarian. J Urol 1997;158:2113.
5. Kolozsy Z. Histopathological "self control" in transurethral resection of bladder tumors. Br J Urol 1991;67:162.
6. Wijkstrom H, Norming U, Lagerkvist M, Nilsson B, Naslund I, Wiklund P. Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: A long-term follow-up of 276 consecutive patients. Br J Urol 1998;81:686.
7. Herr HW. Conservative management of muscle-infiltrating bladder cancer: Prospective experience. J Urol 1987;138:1162.
8. Sobin LH, Wittekind CH (eds). International Union against Cancer TNM Classification of Malignant Tumors, rev 5, ed 4. New York: Wiley-Liss, 1997, p 187.
9. Solsona E, Iborra I, Ricos JV, Monros JL, Dumont R. Feasibility of transurethral resection for muscle-infiltrating carcinoma of the bladder. Prospective study. J Urol 1992;147:1513.
10. Henry K, Miller J, Mori M, Loening S, Fallon B. Comparison of transurethral resection to radical therapies for stage B bladder tumors. J Urol 1988;140:964.
11. O'Flynn JD, Smith JM, Hanson JS. Transurethral resection for the assessment and treatment of vesical neoplasms. Eur Urol 1975;1:38.
12. Roosen JU, Geertson U, Jahn H, Weinreich J, Nissen HM. Invasive, high grade transitional cell carcinoma of the bladder treated with transurethral resection. Scand J Urol Nephrol 1997;31:39.
13. Barnes RW, Dick AL, Hadley HL, Johnston OL. Survival following transurethral resection of bladder carcinoma. Cancer Res 1977; 37:2895.
14. Hall RR, Newling DWW, Ramsden PD, Richards B, Robinson MRG, Smith PH. Treatment of invasive bladder cancer by local resection and high dose methotrexate. Br J Urol 1984;56:668.
15. Thomas DJ, Roberts JT, Hall RR, Reading J. Radical transurethral resection and chemotherapy in the treatment of muscle-invasive bladder cancer: A long-term follow-up BJU Int 1999;83:432.
16. Uygar MC, Yaman I, Altug U, Erol D. Conservative management of stage T2 or T3a bladder cancer with deep transurethral resection followed by four cycles of chemotherapy. Br J Urol 1996;78: 201.
17. Herr HW, Bajorin DF, Scher HI. Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: Ten-year outcome. J Clin Oncol 1998;16:1298.
18. Rotman M, Aral I, Schwartz D, Hussain F, Laungani G, Macchia R. Concomitant continuous infusion chemotherapy and radiation in the treatment of muscle invading bladder carcinoma. Oncology 1994;3:343.
19. Kaufman DS, Shipley WU, Griffin PP, Heney NM, Althausen AF, Efird JT. Selective bladder preservation by combination treatment of invasive bladder cancer. N Engl J Med 1993;329:1377.
20. Zeitman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ. A Phase I/II trial of transurethral surgery combined with concurrent cisplatinum, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer. J Urol 1998;160:1673.
21. Macchia RJ (ed). Alternatives to Radical Cystectomy. Urology 1988;31(suppl).